Episurf Medical06.05.20
Episurf Medical has received a Notice of Allowance from the Korean Intellectual Property Office (KIPO), granting the company’s first patent approval in Korea. The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint” covers Episurf Medical’s 3D-based damage marking technology which constitutes a central part of the Episealer implant system as well as the Epioscopy joint visualization system.
“This is a core patent for Episurf’s imaging technology. We are working towards being able to launch our products in certain Asian markets and maintaining a strong IP portfolio in relevant regions is an important part of that strategy,” said Katarina Flodström, COO, Episurf Medical.
“This is a core patent for Episurf’s imaging technology. We are working towards being able to launch our products in certain Asian markets and maintaining a strong IP portfolio in relevant regions is an important part of that strategy,” said Katarina Flodström, COO, Episurf Medical.